Mettler-Toledo International Inc. (MTD) fair value analysis

S&P 500 · Updated 2026-09-07

Mettler-Toledo International Inc. manufactures and sells precision instruments and services for laboratory, industrial, and retail applications, including analytical balances, pipettes, thermal analysis equipment, and software solutions. The company operates globally across North America, Europe, Asia, and other international markets.

Forward Fair Value verdict

Undervalued

Based on TickrTrends' weekly Forward Fair Value model, MTD is trading at a 10–25% discount to estimated fair value.

MTD currently ranks #47 of 113 Healthcare stocks by discount to Forward Fair Value. It has screened as Undervalued for 3 consecutive weekly runs.

Last price: $1,345.26
Sector: Healthcare
12-month range: $1,183.57–$1,468.09

Derived indicators

Coarse bands from TickrTrends' weekly models; exact figures are part of the full report.

Quality grade: B
Leverage: Low
Margin trend: Stable
Revenue growth: Declining
RSI zone: Oversold
52-week position: The upper-middle quarter of its range

What our data shows for MTD

Our model validated 17 trailing price-to-earnings windows for MTD, built from quarterly earnings records.
Shares are trading in the middle of their 12-month price range of $1,183.57–$1,468.09.
The 14-day relative strength index sits at an oversold 29.

The exact numbers are one step away

The precise Forward Fair Value dollar figure for MTD
Exact discount / premium to today's price
The normalized historical P/E behind the estimate, and how many quarters support it
Forward EPS input and fiscal-year basis
Screeners and rankings across the full S&P 500 and Nasdaq universes

See the exact fair value →

How Forward Fair Value works

TickrTrends computes a Forward Fair Value for every covered stock each week: a conservatively normalized historical price-to-earnings multiple is applied to the analyst-consensus earnings estimate for the next full fiscal year. Every input window is validated for continuity and every result is screened for plausibility before publication.

Recent MTD news

TickrTrends' derived news-sentiment signal for MTD is currently leaning positive, computed from recent coverage.

MTD Initiates Coverage On Mettler-Toledo Intl -- Price Target Announced at $1515 (gurufocus.com, 2026-09-01)
TickrTrends take: An analyst has initiated coverage of Mettler-Toledo International with a price target of $1515, which suggests confidence in the company's medium-term prospects. Given that TickrTrends currently rates MTD as undervalued despite operating in the competitive Healthcare sector, this new price target provides a specific benchmark against which investors can monitor whether the market reprices the stock toward analyst expectations. Valuation-focused observers should track whether MTD's fundamental metrics continue to support the undervalued assessment or whether recent analyst coverage catalyzes broader market recognition of the company's intrinsic value.
Do Wall Street Analysts Like Mettler-Toledo Stock? (finance.yahoo.com, 2026-08-28)
TickrTrends take: Mettler-Toledo operates in the Healthcare sector and is currently assessed as undervalued by TickrTrends. Given this undervaluation designation, analyst sentiment regarding the stock becomes particularly relevant as a potential indicator of whether the market has overlooked value that professional investors recognize. A valuation-focused reader should monitor whether Wall Street analyst assessments align with or diverge from the current undervalued rating, as such alignment or divergence may suggest either confirmation of pricing inefficiency or signals of changing market conditions.

What people are saying

Follow the MTD conversation: Stocktwits · Reddit · X

TickrTrends weekly updates

2026-09-07 — No material change this week: the verdict, bands and grades all held steady.
2026-09-06 — TickrTrends' derived indicators for the Healthcare sector MTD show notable shifts this week. The DCF cross-check band moved from an overvalued assessment to none, while momentum indicators that previously registered at D are now absent from reporting. The RSI zone shifted from neutral to oversold territory, reflecting changed technical positioning within the sector.
2026-08-31 — TickrTrends initiated weekly Forward Fair Value coverage of this stock.

Frequently asked questions

Is MTD stock undervalued?

Based on TickrTrends' Forward Fair Value model (updated 2026-09-07), MTD is trading at a 10–25% discount to estimated fair value and screens as undervalued. The exact fair value and discount are available to subscribers.

What is MTD's TickrTrends verdict?

MTD's current verdict is Undervalued, refreshed with every weekly Forward Fair Value run.

How does MTD compare to other Healthcare stocks?

MTD ranks #47 of 113 Healthcare stocks in TickrTrends' coverage when sorted by discount to Forward Fair Value.

Is MTD overbought or oversold?

MTD's 14-day RSI is in the oversold zone on TickrTrends' latest weekly data.

All Healthcare fair-value coverage →

Head-to-head comparisons

MTD vs BTSG · MTD vs COLL · MTD vs EW · MTD vs EXEL · MTD vs GMAB